ArticleCell death discovery2022
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.
Clara Alcon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleCell death discovery2022
Clara Alcon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.